Skip to main content
. Author manuscript; available in PMC: 2016 Nov 4.
Published in final edited form as: Nature. 2016 May 4;533(7604):481–486. doi: 10.1038/nature17998

Extended Data Figure 2. Circulating levels of ketamine and its metabolites following i.p. administration in mice.

Extended Data Figure 2

a, Plasma and b, brain levels of ketamine (KET) and its metabolites following administration of (R,S)-KET (10 mg/kg) in mice. (c-d) Brain levels of c, KET, d, norketamine (norKET) and e, hydroxynorketamine (HNK) following administration of (S)- and (R)-KET. f, Chemical structure of (R,S)-6,6-dideuteroketamine ((R,S)-d2-KET), which g, displaces [3H]-MK-801 binding with a similar affinity to (R,S)-KET ((R,S)-KET: Ki=799nM (R,S)-d2-KET: Ki=883nM) (statistical analyses and n numbers see Supplementary Information Table 1).